QBFM
AMAG

QS Batterymarch Financial Management’s AMAG Pharmaceuticals AMAG Stock Holding History

QS Batterymarch Financial Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3.61M Sell
113,020
-12,740
-10% -$272K 0.1% 310
2014
Q2 		$2.61M Sell
125,760
-8,534
-6% -$158K 0.07% 388
2014
Q1 		$2.6M Sell
134,294
-44,460
-25% -$944K 0.05% 445
2013
Q4 		$4.34M Sell
178,754
-966
-0.5% -$22.7K 0.09% 338
2013
Q3 		$3.86M Hold
179,720
– – 0.08% 355
2013
Q2 		$4M Buy
+179,720
New +$3.96M 0.08% 380

Other funds holding AMAG

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

QS Batterymarch Financial Management's AMAG Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its AMAG Pharmaceuticals (AMAG) stake by 10% in Q3 2014, selling an estimated $272K and leaving 113,020 shares worth $3.61M. The position accounts for 0.1% of the portfolio, ranked #310.

QS Batterymarch Financial Management first reported a position in AMAG in Q2 2013 and has held it in 6 quarters since. The position peaked at $4.34M in Q4 2013. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2014.

  • QS Batterymarch Financial Management held 113,020 shares of AMAG Pharmaceuticals worth $3.61M as of Q3 2014.
  • QS Batterymarch Financial Management sold 12,740 AMAG Pharmaceuticals shares in Q3 2014, an estimated $272K.
  • AMAG Pharmaceuticals made up 0.1% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #310 holding.
  • QS Batterymarch Financial Management first reported a position in AMAG Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
  • QS Batterymarch Financial Management's AMAG Pharmaceuticals position peaked at $4.34M in Q4 2013.
  • 113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.